0 CHECKOUT

PRODUCT FILTERS

REGION

23
3
3
3
1

COUNTRY

3
1

CATEGORIES

  • 58
  • 9
  • 6
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

21
22
40
97

PUBLISHED

0
9
21
97

PRODUCT TYPE

92
2
1
1
1

Search for: "Millennium Biotechnologies Group, Inc."

97 Products

Inergetics, Inc. (Formerly Millennium Biotechnologies Group, Inc.)Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

Published:  June 2013
Price:  From

Lymphoma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Lymphoma Therapeutics in US$ Million The report provides separate comprehensive analytics for US, Europe, and Rest of World Annual estimates and forecasts...

Published:  April 2010
Price:  From

Prostate Cancer - Pipeline Review, H2 2013

Prostate Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Prostate Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  August 2013
Price:  From

Endometrial Cancer - Pipeline Review, H1 2015

Endometrial Cancer - Pipeline Review, H1 2015 Summary This, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This report provides...

Published:  May 2015
Price:  From

Ovarian Cancer - Pipeline Review, H2 2013

Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  October 2013
Price:  From

Osteosarcoma Global Clinical Trials Review, H2, 2013

Osteosarcoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Osteosarcoma Global Clinical Trials Review, H2, 2013" provides data on the Osteosarcoma clinical trial scenario....

Published:  September 2013
Price:  From

Multiple Myeloma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

Published:  October 2011
Price:  From

Biopharmaceutical Contract Manufacturing Market, 2015 - 2025

Characterized by a rapidly expanding product pipeline and a capital intensive manufacturing business, the biopharmaceutical market is witnessing a growing trend towards contract manufacturing. In addition...

Published:  May 2015
Price:  From

Skin Cancer - Pipeline Review, H1 2013

Skin Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Skin Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  May 2013
Price:  From

Gynecological Cancer - Pipeline Review, H1 2013

Gynecological Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gynecological Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

Published:  May 2013
Price:  From

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s...

Published:  February 2014
Price:  From

Ovarian Cancer - Pipeline Review, H2 2014

Ovarian Cancer - Pipeline Review, H2 2014 Summary This, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2014
Price:  From

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody...

Published:  August 2014
Price:  From

Non-Small Cell Lung Cancer - Pipeline Review, H2 2013

Non-Small Cell Lung Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Non-Small Cell Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

Published:  August 2013
Price:  From

2016 Healthcare Practice and Attorney Rate Report

The 2016 Healthcare Practice and Rate Report examines the hourly rates of Attorneys (partners, counsel, senior associates and associates) at the law firms most active in the healthcare sector. Rates...

Published:  July 2015
Price:  From

Ovarian Cancer - Pipeline Review, H1 2014

Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report...

Published:  April 2014
Price:  From

Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

Non-Small Cell Lung Cancer - Pipeline Review, H1 2015 Summary the, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline. This...

Published:  June 2015
Price:  From

The Future of BioSciences: Four Scenarios for 2020 and their Implications for Human Healthcare

This ground breaking, 132 page report links current information on emerging life sciences technologies with a scenario planning approach to identify growth opportunities and threats between now and...

Published:  June 2006
Price:  From
The Future of BioSciences: Four Scenarios for 2020 and their Implications for Human Healthcare The Future of BioSciences: Four Scenarios for 2020 and their Implications for Human Healthcare - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2015

Hepatocellular Carcinoma - Pipeline Review, H1 2015 Summary the, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline. This...

Published:  June 2015
Price:  From

Hepatocellular Carcinoma - Pipeline Review, H2 2014

Hepatocellular Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Hepatocellular Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline. This...

Published:  November 2014
Price:  From
Loading Indicator

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer, Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.